Please login to the form below
Novasecta
This page shows the latest Novasecta news and features for those working in and with pharma, biotech and healthcare.
Taming the Monster
Many companies still struggle to see the value that marketing brings,” says Ed Corbett, principal, Novasecta.
Latest news
-
Keeping it in the family pays dividends
Gold rush. Novasecta also believes that serial acquisition is not always a Holy Grail. ... Novasecta research showed that the cost of acquisitions doubled in 2016 compared to the previous year, with the median value of the acquisition running at 39 times
More from news
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
The first, my last, my everything
and where they do it,” said Ed Corbett, Partner, Novasecta.
-
Three questions that should anchor your brand strategy
Ed Corbett is a Partner at Novasecta, Europe’s leading pharmaceutical strategy consultancy.
-
Launch excellence: beyond the six-month mantra
By Ed Corbett, Principal at Novasecta, Europe’s leading pharmaceutical strategy consultancy.
-
Escaping the spin cycle of sub-optimal launch
Companies know they need clear processes in place to maximise success at launch”, says Ed Corbett, Principal and Commercial Practice Lead at Novasecta Consulting.
-
How pharma should navigate Artificial Intelligence (AI)
Developing an AI strategy that cuts through the hype. By Ed Corbett, Principal at Novasecta, Europe's leading pharmaceutical strategy consultancy.
More from intelligence
Approximately 2 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Practical Patient Centricity
Putting customers at the centre of businesses is common practice in many industry sectors. Though the pharmaceutical industry has multiple customers, including healthcare professionals and payors, the ultimate customers are always patients. For many
-
Digital Marketing is no Substitute for Sound Strategic Marketing
Novasecta’s experience is that at some level, all companies are flexing their digital muscles – with some more than others. ... Novasecta’s experience is that for companies with a heritage in strong strategic marketing, re-building the marketing
-
Novasecta
We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance improvement and sustainable growth by working with their leaders and teams to develop excellent
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- FDA external report recommends actions to address US opioid crisis
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- The increasing value of rare disease trials
- Wrapping up EAU with a Look at Medscape’s Urology Impact
- MHRA to introduce new UK clinical trials framework
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- Congress is in session – how companies are boosting their impact and engagement
- AstraZeneca announces major expansion of Canadian research footprint
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
PMHub
Porterhouse Medical Group
The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
